Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Role of SMPD3 during Bone Fracture Healing and Regulation of its Expression.

Manickam G, Moffatt P, Murshed M.

Mol Cell Biol. 2018 Dec 10. pii: MCB.00370-18. doi: 10.1128/MCB.00370-18. [Epub ahead of print]

PMID:
30530524
2.

Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice.

Rauch F, Geng Y, Lamplugh L, Hekmatnejad B, Gaumond MH, Penney J, Yamanaka Y, Moffatt P.

Bone. 2018 Feb;107:131-142. doi: 10.1016/j.bone.2017.11.013. Epub 2017 Nov 22.

PMID:
29174564
3.

The osteogenic cell surface marker BRIL/IFITM5 is dispensable for bone development and homeostasis in mice.

Patoine A, Husseini A, Kasaai B, Gaumond MH, Moffatt P.

PLoS One. 2017 Sep 7;12(9):e0184568. doi: 10.1371/journal.pone.0184568. eCollection 2017.

4.

Interactions of AMTN, ODAM and SCPPPQ1 proteins of a specialized basal lamina that attaches epithelial cells to tooth mineral.

Fouillen A, Dos Santos Neves J, Mary C, Castonguay JD, Moffatt P, Baron C, Nanci A.

Sci Rep. 2017 Apr 24;7:46683. doi: 10.1038/srep46683.

5.

Absence of the dermatan sulfate chain of decorin does not affect mouse development.

Moffatt P, Geng Y, Lamplugh L, Nanci A, Roughley PJ.

J Negat Results Biomed. 2017 Apr 17;16(1):7. doi: 10.1186/s12952-017-0074-3.

6.

Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta.

Bardai G, Ward LM, Trejo P, Moffatt P, Glorieux FH, Rauch F.

Osteoporos Int. 2017 Jul;28(7):2095-2101. doi: 10.1007/s00198-017-4031-2. Epub 2017 Apr 4.

PMID:
28378289
7.

DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum.

Bardai G, Moffatt P, Glorieux FH, Rauch F.

Osteoporos Int. 2016 Dec;27(12):3607-3613. Epub 2016 Aug 11.

PMID:
27509835
8.

Smpd3 Expression in both Chondrocytes and Osteoblasts Is Required for Normal Endochondral Bone Development.

Li J, Manickam G, Ray S, Oh CD, Yasuda H, Moffatt P, Murshed M.

Mol Cell Biol. 2016 Aug 12;36(17):2282-99. doi: 10.1128/MCB.01077-15. Print 2016 Sep 1.

9.

Laminin γ2 knockout mice rescued with the human protein exhibit enamel maturation defects.

Wazen RM, Viegas-Costa LC, Fouillen A, Moffatt P, Adair-Kirk TL, Senior RM, Nanci A.

Matrix Biol. 2016 May-Jul;52-54:207-218. doi: 10.1016/j.matbio.2016.03.002. Epub 2016 Mar 5.

PMID:
26956061
10.

Osteogenesis Imperfecta Type VI in Individuals from Northern Canada.

Ward L, Bardai G, Moffatt P, Al-Jallad H, Trejo P, Glorieux FH, Rauch F.

Calcif Tissue Int. 2016 Jun;98(6):566-72. doi: 10.1007/s00223-016-0110-1. Epub 2016 Jan 27.

PMID:
26815784
11.

Osteogenesis Imperfecta Type I Caused by COL1A1 Deletions.

Bardai G, Lemyre E, Moffatt P, Palomo T, Glorieux FH, Tung J, Ward L, Rauch F.

Calcif Tissue Int. 2016 Jan;98(1):76-84.

PMID:
26478226
12.

Inactivation of the Odontogenic ameloblast-associated gene affects the integrity of the junctional epithelium and gingival healing.

Wazen RM, Moffatt P, Ponce KJ, Kuroda S, Nishio C, Nanci A.

Eur Cell Mater. 2015 Sep 28;30:187-99.

13.

Recessive osteogenesis imperfecta caused by missense mutations in SPARC.

Mendoza-Londono R, Fahiminiya S, Majewski J; Care4Rare Canada Consortium, Tétreault M, Nadaf J, Kannu P, Sochett E, Howard A, Stimec J, Dupuis L, Roschger P, Klaushofer K, Palomo T, Ouellet J, Al-Jallad H, Mort JS, Moffatt P, Boudko S, Bächinger HP, Rauch F.

Am J Hum Genet. 2015 Jun 4;96(6):979-85. doi: 10.1016/j.ajhg.2015.04.021. Epub 2015 May 28.

14.

The effect of SERPINF1 in-frame mutations in osteogenesis imperfecta type VI.

Al-Jallad H, Palomo T, Roughley P, Glorieux FH, McKee MD, Moffatt P, Rauch F.

Bone. 2015 Jul;76:115-20. doi: 10.1016/j.bone.2015.04.008. Epub 2015 Apr 11.

PMID:
25868797
15.

Cole-Carpenter syndrome is caused by a heterozygous missense mutation in P4HB.

Rauch F, Fahiminiya S, Majewski J, Carrot-Zhang J, Boudko S, Glorieux F, Mort JS, Bächinger HP, Moffatt P.

Am J Hum Genet. 2015 Mar 5;96(3):425-31. doi: 10.1016/j.ajhg.2014.12.027. Epub 2015 Feb 12.

16.

A framework for estimating health state utility values within a discrete choice experiment: modeling risky choices.

Robinson A, Spencer A, Moffatt P.

Med Decis Making. 2015 Apr;35(3):341-50. doi: 10.1177/0272989X14554715. Epub 2014 Oct 27.

PMID:
25349189
17.

A polyadenylation site variant causes transcript-specific BMP1 deficiency and frequent fractures in children.

Fahiminiya S, Al-Jallad H, Majewski J, Palomo T, Moffatt P, Roschger P, Klaushofer K, Glorieux FH, Rauch F.

Hum Mol Genet. 2015 Jan 15;24(2):516-24. doi: 10.1093/hmg/ddu471. Epub 2014 Sep 11.

PMID:
25214535
18.

Characterisation of secretory calcium-binding phosphoprotein-proline-glutamine-rich 1: a novel basal lamina component expressed at cell-tooth interfaces.

Moffatt P, Wazen RM, Dos Santos Neves J, Nanci A.

Cell Tissue Res. 2014 Dec;358(3):843-55. doi: 10.1007/s00441-014-1989-3. Epub 2014 Sep 6.

PMID:
25193156
19.

Normal bone density and fat mass in heterozygous SERPINF1 mutation carriers.

Al-Jallad H, Palomo T, Moffatt P, Roughley P, Glorieux FH, Rauch F.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2446-50. doi: 10.1210/jc.2014-2505. Epub 2014 Aug 15.

PMID:
25127091
20.

Targeted sequencing of a pediatric metabolic bone gene panel using a desktop semiconductor next-generation sequencer.

Rauch F, Lalic L, Glorieux FH, Moffatt P, Roughley P.

Calcif Tissue Int. 2014 Oct;95(4):323-31. doi: 10.1007/s00223-014-9897-9. Epub 2014 Aug 3.

PMID:
25086671

Supplemental Content

Loading ...
Support Center